Juno pays $42mm in cash and stock to buy X-BODY
Private antibody engineering company X-BODY Inc. was acquired by Juno Therapeutics Inc. Juno paid $21mm in cash, issued 439k of its shares (valued at $21mm), and could hand over earn-outs for R&D, regulatory, and sales achievements.
- Drug Discovery Tools
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Intra-Biotech Deal
- Payment Includes Cash
- Payment Includes Stock
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.